We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Variants Linked to Pollution-Exacerbated Asthma

By LabMedica International staff writers
Posted on 29 Jun 2026

Air-quality advisories often foreshadow symptom flares for people with asthma, yet individual responses to pollution vary widely. More...

Predicting who will be most affected has remained difficult in both routine care and research, in part because the molecular basis for this variability is not well understood. New findings now demonstrate gene–environment interactions linked to oxidative stress that help explain these differences.

University of Pittsburgh School of Public Health, working with the Severe Asthma Research Program (SARP), analyzed nearly 1,000 adults with asthma to identify biological pathways that modulate susceptibility to air pollution. The work, published in eBioMedicine on June 23, 2026, is among the largest and most comprehensive studies of its kind. Investigators combined whole‑genome sequencing, air‑pollution exposure data, and gene‑expression profiling to probe why pollution exacerbates symptoms for some patients more than others.

The analysis concentrated on approximately 450 genes that regulate oxidative stress, a process through which highly reactive molecules can damage cells and tissues. Researchers examined exposure to fine particulate matter (PM2.5), microscopic particles smaller than 2.5 microns that can penetrate deep into the lungs. A first-of-its-kind transcriptomic assessment using human airway samples was performed: bronchial brushings from a subset of about 200 participants enabled direct measurement of how DNA is transcribed into RNA in airway epithelial cells following pollution exposure.

A clear exposure–response relationship emerged across the cohort, linking higher PM2.5 levels to lower lung function in people already living with asthma. Gene activity data showed how pollution altered transcriptional programs in airway cells. 

Genetic analyses identified seven oxidative stress–related genes whose variants appear to influence vulnerability to pollution-exacerbated asthma. Less common variants in OXSR1 and PXDN were associated with disproportionately worse lung function because of weaker protective RNA responses to PM2.5. A specific variant in TPO was also linked to worse lung function, but through stronger RNA responses, highlighting distinct mechanistic pathways. Other variants appeared to either enhance protection or intensify damage.

According to the authors, the molecular pathways identified could inform future therapeutic targets, as well as potential biomarkers and public health strategies for those at greatest risk. Next steps include deeper investigation of these pathways and studies testing whether targeted interventions, from behavioral changes to antioxidant approaches, can blunt the effects of pollution in high-risk individuals.

"You could imagine a simple test for a panel of genes that could be used to flag someone as highly susceptible to the effects of pollution," said Sally Wenzel, M.D., chair of Pitt Public Health’s Department of Environmental and Occupational Health and director of Pitt’s Asthma and Environmental Lung Health Institute at UPMC.

“We’re already exploring some of these pathways. Ultimately, while reducing the amount of pollution remains the most effective approach, the findings from our study suggest we could develop interventions specific to at-risk people that would lessen the impact of pollution,” said Wenzel.

Related Links
University of Pittsburgh School of Public Health


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.